Navigation Links
Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting
Date:3/22/2011

EXTON, Pa., March 22, 2011 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced data presented in two poster presentations relating to Cinryze® (C1 esterase inhibitor [human]) at the 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting, March 18 through 22, in San Francisco, CA.  

Cinryze is the first and only U.S. FDA-approved C1 esterase inhibitor therapy indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), a rare, debilitating and potentially fatal disease.  Cinryze is currently available only in the United States, and is not approved in the U.S. to treat acute angioedema attacks, for children with HAE, or for pre-procedure administration.

"As leaders in hereditary angioedema medical education, we continue to expand the body of data available on Cinryze usage," commented David Mariano, PharmD, ViroPharma's director of medical communications. "Our goal is to leverage educational initiatives to reinforce the understanding and awareness of HAE and its management for physicians and other healthcare professionals who may care for patients suffering from HAE."

AAAAI Poster Presentations

In a poster entitled, 'Pre-procedural Administration of Nanofiltered C1 Esterase Inhibitor (Human) (Cinryze®) for the Prevention of Hereditary Angioedema (HAE) Attacks after Medical, Dental, or Surgical Procedures,' Dr. William Lumry, M.D., of the University of Texas Southwestern Medical School in Dallas, Texas discussed the potential for Cinryze to prevent attacks of HAE that are triggered by trauma such as dental work, elective medical procedures and surgery.  Data compiled from all completed studies with Cinryze were presented on the experience of 41 subjects who received Cinryze prior to 91 procedures.  Cinryze 1000U
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
2. Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO)
3. ViroPharma Receives Complete Response Letter for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Supplement
4. ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
5. ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing
6. Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care
7. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
8. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
9. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
10. iTherX Initiates Phase 1b Study of First-in-Class Hepatitis C Virus Entry Inhibitor ITX-5061
11. N30 Pharmaceuticals to Present S-Nitrosoglutathione Reductase Inhibitor Preclinical Safety Data at 2011 Society of Toxicology 50th Anniversary Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Boston Scientific Corporation (NYSE: BSX ) ... Program May 21-24 in Paris . ... rich and diversified set of data this year at ... global chief medical officer, Boston Scientific.  "The primary endpoint ... NG PROMUS trial, which evaluated our Promus PREMIER ™ ...
(Date:5/16/2013)... NORTH CHICAGO, Ill. and MECHELEN, ... NV (Euronext: GLPG) and AbbVie (NYSE: ABBV ... development collaboration to include Crohn,s disease.  Galapagos will fund ... which is designed to facilitate rapid progression into Phase ... Q2 2015, AbbVie will pay Galapagos $50 million.  The ...
(Date:5/16/2013)... FRANCISCO , May 16, 2013  Nektar Therapeutics, (Nasdaq: ... Howard W. Robin , is scheduled to present ... New York at the Sheraton New York ... time. The presentation will be accessible via a ... Calendar section of the Nektar website: http://www.nektar.com . This ...
Breaking Medicine Technology:Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... Similar to Seven-Day in, Achieving Red Blood Cell Transfusion Independence, ... ... Data Presented at the 49th American Society of Hematology (ASH) ... ) today announced interim data from a Phase 2 clinical ...
... of Severe Cardiac Toxicity With Equivalent ... Complete Remission Rates ... (Nasdaq and MTAX: CTIC) announced today that preliminary data ... in the,first-line treatment of patients with aggressive non-Hodgkin,s lymphoma,(NHL) ...
Cached Medicine Technology:MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 2MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 3MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 4MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 5MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 6Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 2Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 3Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 4Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 5
(Date:5/20/2013)... May 20, 2013 Healing Heart Urgent ... newest office on Briarcliff Road in the Druid Hills ... facility includes Dr. Fidias E. De León M.D. and ... will provide extensive medical services, occupational health, chiropractic care ... Atlanta metropolitan area. They also offer a full range ...
(Date:5/20/2013)... 20, 2013 AURORA, Colo. – May ... accredited university, has developed a Bachelor of Science ... how they feel about continuing their education and gauge ... out the complimentary worksheet, respond to ten statements and ... rate on a BSN-readiness scale. , New industry standards ...
(Date:5/20/2013)... NY (PRWEB) May 20, 2013 InVite® ... City, today announced the introduction of its new ... that provides high density nutrition with plant extracts from ... herbs, spices, royal jelly, apple pectin, plant enzymes and ... offers the micronutrients and antioxidant levels of several servings ...
(Date:5/20/2013)... Can you tell a joke well? , Do people roll their ... like to be funnier as a speaker, teacher, presenter of any ... missing? , Can't think of a snappy comeback when someone hits ... like you, don't worry. Help is here. I believe ... even learn to tell a joke well. I am not kidding. ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 FixturesAndDisplays.com, the ... comprehensive selection of high-quality retail clothing display options to ... and upscale retailers. Their expansive product line includes ... broad range of mannequin options. Recently ... its most popular models in reformulated “green” versions. ...
Breaking Medicine News(10 mins):Health News:Healing Heart Urgent Care Opens New Office In Atlanta 2Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 2Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 3Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 2Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 3Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 2Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 3Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 4Health News:FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays 2Health News:FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays 3
... , , , ... has been invited to participate in the inaugural Australian Paralympic ... basketball team includes nine athletes and three coaches from Courage ... 5-11 at the Melbourne Sports & Aquatic Centre. The Paralympic ...
... , WASHINGTON, Sept. 23 Speaker Nancy ... Legislative Conference "Capitol Hill Day Summit" this morning in the Capitol ... , , "Thank you, Chairwoman Barbara ... conscience of the Congress. , , "Essential ...
... , STAMFORD, Conn., Sept. 23 AmeriCares this ... States at the 2009 Clinton Global Initiative in New York ... CEO Curt Welling, is a two-year commitment to improve community ... organizations serving the uninsured and underinsured throughout the country. ...
... , , , ... announces their Second Annual Fellowship Convention to be held at ... California. , , Founded in 1998, FA is ... support, are recovering from food addiction. For many people who ...
... series of cases with commentaries by the American ... Rights Committee and the College,s Center for Ethics ... http://cme.medscape.com/viewpublication/30131. "The ethical dilemmas presented are very ... MD, FACP, ACP President. "Learning from case studies ...
... capsules that show a tendency in the standard laboratory test ... and potentially unsafe manner in patients who have consumed alcohol ... with testing in people. That,s the conclusion of a ... Molecular Pharmaceutics , a bi-monthly journal. In ...
Cached Medicine News:Health News:12 Local Athletes and Coaches Chosen for U.S. Wheelchair Basketball Team 2Health News:Pelosi Remarks at the Congressional Black Caucus Foundation's Annual Legislative Conference 2Health News:Pelosi Remarks at the Congressional Black Caucus Foundation's Annual Legislative Conference 3Health News:AmeriCares Expands Medical Assistance Across the United States 2Health News:AmeriCares Expands Medical Assistance Across the United States 3Health News:Food Addicts Convention Draws 800 Members from 31 States, 5 Nations Around the World 2Health News:Food Addicts Convention Draws 800 Members from 31 States, 5 Nations Around the World 3
An immunochromatographic test for detection of 4 species of Plasmodium antigen ( P. falciparum , P. vivax , P. malariae , P. ovale ) in whole blood....
Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)...
... Biotech Uni-Gold™ Pf Malaria Test is ... the presence of Plasmodium falciparum ... is an antigen-capture assay detecting presence ... rich protein II (PfHRP- II), which ...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Medicine Products: